Updated on 14 Oct 2026, 12:33 PM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,742.40 | -1.51 | 4,18,050.27 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,116.00 | -1.71 | 2,42,001.15 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,606.00 | -0.63 | 1,75,191.17 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,315.50 | -1.09 | 1,06,273.77 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,130.00 | -0.09 | 1,12,717.93 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-08-12 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-01-21 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-10-14 | Others |
Indo US Bio-Tech is trading at 72.00 as on Tue Oct 13 2026 04:07:47. This is 0.00% upper as compared to its previous closing price of 72.00.
The market capitalization of Indo US Bio-Tech is 144.37 Cr as on Tue Oct 13 2026 04:07:47.
The 52 wk high for Indo US Bio-Tech is 158.85 whereas the 52 wk low is 71.02
Indo US Bio-Tech can be analyzed on the following key metrics -
Indo US Bio-Tech reported a net profit of 13.12 Cr in 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.